Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Gentak

CompanyAkorn (DUNS: 117693100)

Effective Date

January 28, 2022

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Gentamicin(3 mg in 1 g)

Registrants (1)

Akorn Operating Company LLC

DUNS Number

117693100

Manufacturing Establishments (1)

Labeler

Akorn

Registrant

Akorn Operating Company LLC

DUNS Number

117696840

Products (1)

Gentak

NDC Product Code

17478-284

Application Number

ANDA064093

Marketing Category

ANDA (C73584)

Route of Administration

OPHTHALMIC

Effective Date

March 2, 2012

Ingredients

GentamicinActive

Code: 8X7386QRLVClass: ACTIMQuantity: 3 mg in 1 g

PetrolatumInactive

Code: 4T6H12BN9UClass: IACT

MethylparabenInactive

Code: A2I8C7HI9TClass: IACTQuantity: 0.5 mg in 1 g

PropylparabenInactive

Code: Z8IX2SC1OHClass: IACTQuantity: 0.1 mg in 1 g

Mineral OilInactive

Code: T5L8T28FGPClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy